Abstract
A retrovirus is an RNA virus encoding for a reverse transcriptase, which translates the viral RNA into a DNA provirus that is rapidly incorporated into the host’s genome [1]. Retrovirus infections affect the systemic immune status and cause various diseases, including ocular diseases [2]. Retroviruses are currently classified as either oncoviruses or lentiviruses. Oncoviruses are associated with hematological proliferations and tumors of the connective tissues [3]. Human T-cell leukemia viruses (HTLVs) are representative oncoviruses, and HTLV-1 was the first retrovirus described as being a causative agent of human disease [4, 5]. Lentiviruses induce chronic and progressive pulmonary and/or neurological diseases. Human HIV is a representative of such viruses and is the causative agent of acquired immune deficiency syndrome [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
G DT (1989) HTLV-1 and chronic progressive encephalomyelopathies: an immunovirological perspective. Alan R Liss, New York
Kamoi K, Mochizuki M (2012) HTLV infection and the eye. Curr Opin Ophthalmol 23:557–561
Poiesz BJ, Ruscetti FW, Gazdar AF et al (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7415–7419
Yoshida M, Seiki M, Yamaguchi K et al (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81:2534–2537
Gallo RC (2005) The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2:17
Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407–410
Osame M, Usuku K, Izumo S et al (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031–1032
Mochizuki M, Watanabe T, Yamaguchi K et al (1992) Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol 114:123–129
Mochizuki M, Watanabe T, Yamaguchi K et al (1992) Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis 166:943–944
Mochizuki M, Yamaguchi K, Takatsuki K et al (1992) HTLV-1 and uveitis. Lancet 399:1110
Ohba N, Matsumoto M, Sameshima M et al (1989) Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 33:1–12
Shirao M, Yoshimura K, Mochizuki M et al (1993) Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers – 1. A seroepidemiological study. Nippon Ganka Gakkai Zasshi 97:726–732
Yoshimura K, Shimada N, Shirao M et al (1993) Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers – 2. An analysis of clinical features. Nippon Ganka Gakkai Zasshi 97:733–740
Nakashima S, Shirao M, Mochizuki M et al (1993) Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers – 3. A molecular biological study. Nippon Ganka Gakkai Zasshi 97:741–746
Yoshimura K, Mochizuki M, Araki S et al (1993) Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis. Am J Ophthalmol 116:156–163
Watanabe T (2011) Current status of HTLV-1 infection. Int J Hematol 94:430–434
Iwanaga M, Chiyoda S, Kusaba E et al (2009) Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000–2006. Int J Hematol 90:186–190
Uchimaru K, Nakamura Y, Tojo A et al (2008) Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area. Int J Hematol 88:565–570
Miyanaga M, Shimizu K, Kawaguchi T et al (2009) A clinical survey of uveitis in HTLV-1 endemic region. Ocul Immunol Inflamm 17:335–341
Takahashi T, Takase H, Urano T et al (2000) Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up. Ocul Immunol Inflamm 8:235–241
Merle H, Cabre P, Olindo S et al (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134:190–195
Pinheiro SR, Martins-Filho OA, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142:811–815
Yamamoto JH, Segurado AA, Hirata CE et al (1999) Human T-cell lymphotropic virus type 1 infection and ocular manifestations in Sao Paulo, Brazil. Arch Ophthalmol 117:513–517
Ikeda E, Ono A, Hikita N et al (1998) Estimated prevalence rate of HTLV-I uveitis in Chikugo. Nippon Ganka Gakkai Zasshi 102:327–332
Osame M, Janssen R, Kubota H et al (1990) Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 28:50–56
Yamaguchi K, Mochizuki M, Watanabe T et al (1994) Human T lymphotropic virus type 1 uveitis after Graves’ disease. Br J Ophthalmol 78:163–166
Mochizuki M, Sugita S, Kamoi K (2013) Immunological homeostasis of the eye. Prog Retin Eye Res 33:10–27
Ono A, Mochizuki M, Yamaguchi K et al (1997) Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids. Invest Ophthalmol Vis Sci 38:676–689
Sagawa K, Mochizuki M, Masuoka K et al (1995) Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest 95:852–858
Ono A, Ikeda E, Mochizuki M et al (1998) Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves’ disease and disease activities. Jpn J Cancer Res: Gann 89:608–614
Poetker SK, Porto AF, Giozza SP et al (2011) Clinical manifestations in individuals with recent diagnosis of HTLV type I infection. J Clin Virol: the official publication of the Pan American Society for Clinical Virology 51:54–58
Kamoi K, Mochizuki M (2012) HTLV-1 uveitis. Front Microbiol 3:270
Sugita S, Ogawa M, Shimizu N et al (2013) Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology 120:1761–1768
Sagawa K, Mochizuki M, Katagirl K et al (1996) In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis. Microbiol Immunol 40:373–379
Yasunaga J, Matsuoka M (2011) Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol 94:435–442
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kamoi, K., Mochizuki, M. (2017). Human T-Cell Leukemia Virus Type 1. In: Chee, SP., Khairallah, M. (eds) Emerging Infectious Uveitis. Springer, Cham. https://doi.org/10.1007/978-3-319-23416-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-23416-8_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23415-1
Online ISBN: 978-3-319-23416-8
eBook Packages: MedicineMedicine (R0)